Clinical trial
Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean…
NCT00237991 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00237991 |
|---|---|
| Title | Safety of GlaxoSmithKline (GSK) Biologicals Hepatitis A Vaccine in Korean Population |
| Official title | A Multicentric, Post-Marketing Surveillance to Monitor the Safety and Reactogenicity of GlaxoSmithKline Biologicals Hepatitis A Vaccine Administered in Korean Population. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Hepatitis A |
| Intervention type | Biological |
| Interventions | Hepatitis A |
| Enrollment | 600 |
| Start date | Jun 1, 2005 |
| First posted | Oct 13, 2005 |
| Last update posted | Oct 16, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: